Abstract P3-11-15: Different clinical usefulness of AJCC response criteria according to the subtypes in stage II/III breast cancer patients after neoadjuvant chemotherapy

Mapping Intimacies ◽

10.1158/1538-7445.sabcs14-p3-11-15 ◽

2015 ◽

Author(s):

Yaewon Yang ◽

Seock-Ah Im ◽

Tae-Yong Kim ◽

Kyung-Hun Lee ◽

Bhumsuk Keam ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Cancer Patients ◽

Clinical Usefulness ◽

Stage Ii ◽

Response Criteria ◽

Breast Cancer Patients

Download Full-text

Clinical Usefulness of Ajcc Response Criteria in Stage Ii/Iii Breast Cancer Patients Who Treated with Long Course Neoadjuvant Chemotherapy

Annals of Oncology ◽

10.1093/annonc/mdu328.14 ◽

2014 ◽

Vol 25 ◽

pp. iv114

Author(s):

Y. Yang ◽

S. Im ◽

B. Keam ◽

K. Lee ◽

T. Kim ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Cancer Patients ◽

Clinical Usefulness ◽

Stage Ii ◽

Response Criteria ◽

Breast Cancer Patients ◽

Download Full-text

Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses

10.1186/s12885-016-2500-1 ◽

2016 ◽

Vol 16 (1) ◽

Author(s):

Yaewon Yang ◽

Seock-Ah Im ◽

Bhumsuk Keam ◽

Kyung‑Hun Lee ◽

Tae‑Yong Kim ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Cancer Patients ◽

Breast Cancer Subtype ◽

Stage Ii ◽

Response Criteria ◽

Prognostic Impact ◽

Breast Cancer Patients ◽

Download Full-text

FDG PET evaluation of early axillary lymph node response to neoadjuvant chemotherapy in stage II and III breast cancer patients

European Journal of Nuclear Medicine and Molecular Imaging ◽

10.1007/s00259-011-1735-y ◽

2011 ◽

Vol 38 (6) ◽

pp. 1029-1036 ◽

Author(s):

Caroline Rousseau ◽

Anne Devillers ◽

Mario Campone ◽

Loïc Campion ◽

Ludovic Ferrer ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Cancer Patients ◽

Fdg Pet ◽

Axillary Lymph Node ◽

Stage Ii ◽

Axillary Lymph ◽

Breast Cancer Patients ◽

Response To Neoadjuvant Chemotherapy

Download Full-text

The influence of neoadjuvant chemotherapy on surgeon practice patterns for stage II breast cancer patients

Journal of the American College of Surgeons ◽

10.1016/j.jamcollsurg.2006.05.183 ◽

2006 ◽

Vol 203 (3) ◽

pp. S70

Author(s):

Jennifer F. Waljee ◽

Lina Patel-Parekh ◽

Kirby Bland ◽

Lisa Newman

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Cancer Patients ◽

Practice Patterns ◽

Stage Ii ◽

Breast Cancer Patients

Download Full-text

Biweekly docetaxel and gemcitabine as neoadjuvant chemotherapy followed by adjuvant doxorubicin and cyclophosphamide therapy in stage II and III breast cancer patients: results of a phase II study

Clinical & Translational Oncology ◽

10.1007/s12094-007-0059-7 ◽

2007 ◽

Vol 9 (5) ◽

pp. 317-322 ◽

Author(s):

L. G. Estévez ◽

P. Sánchez-Rovira ◽

M. Dómine ◽

A. León ◽

I. Calvo ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Stage Ii ◽

Breast Cancer Patients ◽

Cyclophosphamide Therapy

Download Full-text

Clinical outcomes according to molecular subtypes in stage II-III breast cancer patients treated with neoadjuvant chemotherapy followed by surgery and radiotherapy

Asia-Pacific Journal of Clinical Oncology ◽

10.1111/ajco.12652 ◽

2016 ◽

Vol 13 (4) ◽

pp. 329-336 ◽

Author(s):

Hakyoung Kim ◽

Won Park ◽

Seung Jae Huh ◽

Doo Ho Choi ◽

Jae Myoung Noh ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Cancer Patients ◽

Clinical Outcomes ◽

Molecular Subtypes ◽

Stage Ii ◽

Breast Cancer Patients

Download Full-text

Test of a Weight Gain Prevention Intervention in Stage II and III Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

Cancer Epidemiology Biomarkers & Prevention ◽

10.1158/1055-9965.epi-19-3-aspo12 ◽

2010 ◽

Vol 19 (3) ◽

pp. 895.2-896 ◽

Author(s):

K Basen-Engquist ◽

H Perkins ◽

C Carmack ◽

D Hughes ◽

J Jovanovic ◽

...

Keyword(s):

Breast Cancer ◽

Weight Gain ◽

Neoadjuvant Chemotherapy ◽

Cancer Patients ◽

Stage Ii ◽

Weight Gain Prevention ◽

Breast Cancer Patients ◽

Prevention Intervention

Download Full-text

Is regional lymph node irradiation necessary in stage II to III breast cancer patients with negative pathologic node status after neoadjuvant chemotherapy?

Breast Diseases A Year Book Quarterly ◽

10.1016/j.breastdis.2011.01.040 ◽

2011 ◽

Vol 22 (1) ◽

pp. 82-84

Author(s):

J.D. Mancias ◽

A.G. Taghian

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Cancer Patients ◽

Regional Lymph Node ◽

Stage Ii ◽

Breast Cancer Patients ◽

Node Status ◽

Lymph Node Irradiation

Download Full-text

The role of postmastectomy radiotherapy in clinically node-positive, stage II-III breast cancer patients with pathological negative nodes after neoadjuvant chemotherapy: an analysis from the NCDB

10.18632/oncotarget.6664 ◽

2015 ◽

Vol 7 (17) ◽

pp. 24848-24859 ◽

Author(s):

Jieqiong Liu ◽

Kai Mao ◽

Shuai Jiang ◽

Wen Jiang ◽

Kai Chen ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Cancer Patients ◽

Stage Ii ◽

Breast Cancer Patients ◽

Postmastectomy Radiotherapy ◽

Node Positive ◽

Clinically Node Positive

Download Full-text

The impacts of chemotherapeutic response for clinical stage II and III breast cancer patients after neoadjuvant chemotherapy

Therapeutic Radiology and Oncology ◽

10.21037/tro.2018.01.01 ◽

2018 ◽

Vol 2 ◽

pp. 13-13

Author(s):

Sheng-Hung Wang ◽

Chu-Ping Pi ◽

Tung-Hao Chang ◽

Mu-Tai Liu ◽

Chia-Chun Huang ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Cancer Patients ◽

Clinical Stage ◽

Stage Ii ◽

Breast Cancer Patients ◽

Chemotherapeutic Response

Download Full-text